HIGHLIGHTS
- who: Jennifer Cautela and collaborators from the Myocarditis is a rare but life-threatening adverse event of cancer treatments with immune checkpoint inhibitors (ICIs)Recent guidelines recommend the use of high doses of corticosteroids as a first-line treatment, followed by intensified immunosuppressive therapy (IIST) in the case of unfavorable evolution. However, this strategy is empirical, and no studies have specifically addressed this issue. Therefore, we aimed to investigate and compare the clinical course, management and outcome of ICI-induced myocarditis patients requiring or not requiring IIST. Methods This case-control study included all patients consecutively admitted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.